Kiko sa DOH: Sinovac jabs kanselahin dahil sa mababang efficacy rate

Kiko sa DOH: Sinovac jabs kanselahin dahil sa mababang efficacy rate

January 13, 2021 @ 7:06 PM 2 days ago

  •  
  •  
  •  

Manila, Philippines — Nanawagan si Senator Francis Pangilinan sa Department of Health (DOH) na kanselahin ang pagbili ng China’s Sinovac vaccine.

Ito ay dahil sa napag-alaman sa Brazil trial na nasa 50.4 percent effective lamang ito sa pag-iwas sa new coronavirus SARS-CoV-2.

“Sinovac, with just over 50%  efficacy is 6 times more expensive than AztraZeneca which in contrast shows 70% efficacy,” saad ni Pangilinan sa Twitter.

“Sinovac is more expensive yet having almost 20% lower efficacy. Given these latest findings, we call on the DoH to cancel the purchase of Sinovac vaccines.” RNT/FGDC


  •  
  •  
  •  

Loading...